Skip to content
Navigate to homepage - Cerba Research

CerbACT Asia receives CAP Certification

Cerba Research is happy to announce that our CerbACT lab in Taiwan has received its CAP Certification. CerbACT Asia is a joint venture between Cerba Research and ACT Genomics to create a purpose-built lab facility in Taiwan covering the Asia Pacific region.  

This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services. Deep scientific expertise from both sides of this strategic alliance will support new growth areas for biotech and pharma clients globally and drive better patient outcomes across all phases of clinical trials. 

The expansion includes investments in a new facility in Taipei (Taiwan) and state-of-the-art technologies to strengthen capabilities and services offered to our clients on a truly global scale:

  • Cutting-edge flow cytometry technologies
  • Exploratory as well as In Vitro Diagnostic histopathology services
  • Peripheral blood mononuclear cell (PBMC) isolations from blood and soft tissues

Reach out to our experts and discover how we can help you advance your research

Contact Us